Structure-function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Understanding oncogenic variants is crucial for developing targeted cancer therapies.
• Epidermal Growth Factor Receptor (EGFR) Kinase Domain Duplication (EGFR-KDD) is a recently identified in-frame tandem duplication of EGFR exons 18-25.
• ERBB family Kinase Domain Duplications (KDDs) are implicated as recurrent oncogenic events in various human cancers.

Purpose of the Study:

• To investigate the prevalence of ERBB family KDDs across diverse human cancers.
• To elucidate the functional biochemistry of EGFR-KDD in cancer pathogenesis.
• To evaluate EGFR-KDD as a potential therapeutic target.

Main Methods:

• Computational and experimental analyses were employed to characterize EGFR-KDD.
• Time-resolved fluorescence microscopy and co-immunoprecipitation were used to study EGFR-KDD dimerization.
• Assays were performed to assess the efficacy of inhibiting EGFR-KDD activity.

Main Results:

• EGFR-KDD functions through asymmetric intra-molecular (EGF-independent) and inter-molecular (EGF-dependent) dimerization.
• EGFR-KDD forms ligand-dependent homo- and hetero-dimers/multimers.
• Maximal inhibition of EGFR-KDD activity was achieved by simultaneously blocking both intra- and inter-molecular dimerization.

Conclusions:

• A novel model of EGFR dimerization has been defined, enhancing understanding of EGFR activation mechanisms.
• EGFR-KDD represents a significant oncogenic event in multiple cancers, informing personalized treatment strategies.
• Targeting both intra- and inter-molecular dimerization of EGFR-KDD offers a promising therapeutic approach for patients with relevant tumors.